Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (PSP94) family member

Details for Australian Patent Application No. 2005250059 (hide)

Owner Ambrilia Biopharma Inc.

Inventors Wu, Jinzi Jason; Annabi, Borhane; Hawkins, Robert; Daigneault, Luc; Lamy, Sylvie; Panchal, Chandra J.; Ruiz, Marcia; Beliveau, Richard; Bouzeghrane, Mounia; Garde, Seema

Agent FB Rice

Pub. Number AU-A-2005250059

PCT Pub. Number WO2005/118623

Priority 11/004,270 02.12.04 US; 11/004,273 02.12.04 US; 10/857,358 01.06.04 US; 10/948,229 24.09.04 US

Filing date 21 March 2005

Wipo publication date 15 December 2005

International Classifications

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118623 Priority application(s): WO2005/118623

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250060-Continuous positive flow backflash prevention system

2005250058-Safety system and method